DiscoverBecker Private Equity & Business PodcastTop 5 Drug Trends: Microdosing, GLP-1s, Cannabis Testing, ADHD Treatment, and Medical Spa Investments 9-4-24
Top 5 Drug Trends: Microdosing, GLP-1s, Cannabis Testing, ADHD Treatment, and Medical Spa Investments 9-4-24

Top 5 Drug Trends: Microdosing, GLP-1s, Cannabis Testing, ADHD Treatment, and Medical Spa Investments 9-4-24

Update: 2024-09-04
Share

Description

In this episode, Scott Becker explores five emerging drug trends, including the rise of microdosing psychedelics for joint pain, expanded uses of GLP-1s, the complexities of cannabis testing, evolving approaches to adult ADHD treatment, and the booming medical spa industry driven by private equity investments.

Comments 
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Top 5 Drug Trends: Microdosing, GLP-1s, Cannabis Testing, ADHD Treatment, and Medical Spa Investments 9-4-24

Top 5 Drug Trends: Microdosing, GLP-1s, Cannabis Testing, ADHD Treatment, and Medical Spa Investments 9-4-24

Scott Becker